Covance has access to unique proprietary data sets that other CROs do not, allowing it to design stronger protocols faster and recruit patients more efficiently with fewer non-performing sites than industry averages. This data includes real-world clinical lab results on over 150 million patients that can help assess eligible patient populations based on inclusion/exclusion criteria, as well as performance data from over 175,000 investigator sites globally to better predict future investigator performance and capacity.

1. Not all data is created equal. In fact, other
CROs don’t have access to the unique
combination of Covance data sets. Leveraging
our proprietary data enables us to deliver
strong, viable protocol designs, faster patient
recruitment and fewer non-performing sites
than the industry average.
THERE’S
DATA.
ANDTHEN
THERE’S
COVANCE
DATA.
*

2. REAL-TIME DATA. REAL-WORLD IMPACT.
TALK TO A REPRESENTATIVE TO FIND OUT HOW COVANCE CAN IMPACT YOUR STUDIES.
LEARN MORE AT COVANCE.COM/REALIMPACT
Covance is the drug, medical device and diagnostics
business segment of LabCorp, a leading global life
sciences company. COVANCE is a registered trademark
and the marketing name for Covance Inc. and its
subsidiaries around the world.
*Average time savings based on an analysis
of trials processed through Covance Central
Labs with Protocol Finalization date after
1/1/2009 for the specific clinical indication.
Past performance is not a guarantee of future
results, and a variety of factors other than
CRO performance can impact timing of
clinical studies.
The Americas +1.888.COVANCE (+1.888.268.2623)
+1.609.452.4440
Europe/Africa +00.800.2682.2682
+44.1423.500888
Asia Pacific +800.6568.3000 +65.6.5686588
© Copyright 2019 Covance Inc. INFCDS014-1119
LABCORP DATA
Find Patients That Meet Your
Inclusion/Exclusion Criteria
Using LabCorp’s real-world, de-identified
clinical laboratory data on over 150 million
patients, we can assess populations who
meet your protocol’s eligibility criteria
and accurately model the impact that
the protocol inclusion/exclusion criteria
will have on the patient pool size.
COVANCE CENTRAL
LABS DATA
Pinpoint Investigators
Covance generates more clinical trial
data than anyone else in the world. Our
global proprietary data helps us predict
future investigator performance and
capacity to run multiple studies.
PATIENT DIRECT
A Direct Connection for
Finding Potential Participants
We have access to ~150 million patients
and have a rapidly growing database
of people who have given us permission
to reach out directly to them for
participation in clinical studies.
PATIENT INTELLIGENCE
Strengthen Your Protocol
with Patient Insights
Design your protocol around
actual feedback from potential
patients to elevate your
recruitment and retention rates.
30 Billion
test results
>2.5 Million
patient specimens per week
Processes >5,000
diagnostic assays
including genotype data
150 Million
Patients
in the patient pool
~150 Million Patients ~50%
of U.S. population
~1,900
Patient Service Centers
Faster
Recruitment
by contacting patients directly
Rapidly
Growing
Database
Global
Footprint
~30 Countries
Global Voice of Patient
data collected across
>15,000
historical protocols
14 Million
patients
4.4 Million
kits shipped
per year
102 Countries
over 175,000 Sites
Every day our data grows,
deepening our insights to make
your studies more efficient.
Critical, patient-centric insights
extend your market outreach
and strengthen your studies.
50 Indications
as of October 2019